By Ethan Covey
Identifying patients with rheumatoid arthritis (RA) who may be at risk for nonadherence to treatment and targeting them via pharmacist-led interventions may reduce their risk—and even address nonadherence before it occurs.
The results of a study on predicting nonadherence with RA treatment were presented at the NASP 2024 Annual Meeting & Expo, in Nashville, Tenn.
People with RA can experience increased disease activity and poor health outcomes if they do not adhere to